UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort

Journal of the American Academy of Dermatology, 2016-03, Vol.74 (3), p.455-461.e1

2016

Volltextzugriff (PDF)

Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy

Journal of the American Academy of Dermatology, 2015-05, Vol.72 (5), p.809-815.e1

2015

Volltextzugriff (PDF)

Metastatic papillary thyroid cancer to cerebellum with incidental medullary microcarcinoma

Clinical case reports, 2022-09, Vol.10 (9), p.e6207-n/a

2022

Volltextzugriff (PDF)

Paraneoplastic bullous pemphigoid – A sign of clear cell renal carcinoma

Urology case reports, 2020-05, Vol.30, p.101119, Article 101119

2020

Volltextzugriff (PDF)

A 16-kb Antifuse One-Time-Programmable Memory in 5-nm High-K Metal-Gate FinFET CMOS Featuring Bootstrap High-Voltage Scheme, Read Endpoint Detection, and Pseudodifferential Sensing

IEEE solid-state circuits letters, 2021, Vol.4, p.170-173

2021

Volltextzugriff (PDF)

Parathyroid Frozen Section Interpretation via Desktop Telepathology Systems: A Validation Study

Journal of pathology informatics, 2018-01, Vol.9 (1), p.41-41, Article 41

2018

Volltextzugriff (PDF)

Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events

Journal of the American Academy of Dermatology, 2020-02, Vol.82 (2), p.311-316

2020

Volltextzugriff (PDF)

A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab

Melanoma research, 2015-06, Vol.25 (3), p.265-268

2015

Volltextzugriff (PDF)

Isolated cutaneous panniculitis in Sjögren’s disease exacerbated by COVID-19 illness

Clinical rheumatology, 2024-10, Vol.43 (10), p.3257-3258

2024

Volltextzugriff (PDF)

Mass Forming Basement Membrane Material Secondary to Adnexal Adenocarcinoma - a Case Report

International journal of surgical pathology, 2022-12, Vol.30 (8), p.908-911

2022

Volltextzugriff (PDF)

Acute Truncal Lymphedema Secondary to Axillary Metastatic Melanoma Presenting Like Cellulitis

Case reports in medicine, 2017-01, Vol.2017 (2017), p.1-3

2017

Volltextzugriff (PDF)

High concordance rate of HER2 status assessed via silver in situ hybridisation (SISH) between core biopsy and excision specimens: a 4 year retrospective review from a single institution

Pathology, 2014-04, Vol.46 (3), p.240-241

2014

Volltextzugriff (PDF)

Cutaneous Nodules in the Genital Area in a Patient With Chronic Graft-vs-Host Disease

JAMA dermatology (Chicago, Ill.), 2017-05, Vol.153 (5), p.465

2017

Volltextzugriff (PDF)

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies

Melanoma research, 2016-08, Vol.26 (4), p.413-416

2016

Volltextzugriff (PDF)

PD‐1 inhibitor‐associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculation—Report of 4 cases

Journal of cutaneous pathology, 2017-10, Vol.44 (10), p.851-856

2017

Volltextzugriff (PDF)

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature

Melanoma research, 2018-12, Vol.28 (6), p.491-501

2018

Volltextzugriff (PDF)

Histologic Assessment of Lichenoid Dermatitis Observed in Patients With Advanced Malignancies on Antiprogramed Cell Death-1 (anti-PD-1) Therapy With or Without Ipilimumab

The American journal of dermatopathology, 2017-01, Vol.39 (1), p.23-27

2017

Volltextzugriff (PDF)

Dermoscopic image of radiotherapy associated benign lymphangiomatous papules

BMJ case reports, 2023-09, Vol.16 (9), p.e257598

2023

Volltextzugriff (PDF)

Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma

Melanoma research, 2019-04, Vol.29 (2), p.172-177

2019

Volltextzugriff (PDF)

Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils

Melanoma research, 2017-12, Vol.27 (6), p.641-644

2017

Volltextzugriff (PDF)

Panniculitis in patients treated with BRAF inhibitors: a case series

The American journal of dermatopathology, 2014-06, Vol.36 (6), p.493-497

2014

Volltextzugriff (PDF)

Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.729-737

2021

Volltextzugriff (PDF)

Extranodal NK/T cell lymphoma, nasal type presenting as widespread cutaneous rash

Pathology, 2016-02, Vol.48, p.S119-S119

2016

Volltextzugriff (PDF)

Duodenal plasma cells correspond to serum IgA in common variable immunodeficiency

Pathology, 2021-06, Vol.53 (4), p.503-507

2021

Volltextzugriff (PDF)

Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma

Journal of immunotherapy (1997), 2018-09, Vol.41 (7), p.343-349

2018

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(41)
Humans
(27)
Dermatology
(19)
Female
(16)
Male
(14)
Middle Aged
(12)
Oncology
(12)
Aged
(10)
Medicine, Research & Experimental
(8)
Melanoma - Drug Therapy
(8)
Pathology
(8)
Research & Experimental Medicine
(8)
Skin Neoplasms - Drug Therapy
(7)
Skin Neoplasms - Pathology
(7)
Melanoma
(6)
Pembrolizumab
(6)
Programmed Cell Death 1 Receptor - Antagonists & Inhibitors
(6)
Adult
(5)
Antineoplastic Agents - Adverse Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort

Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy

Metastatic papillary thyroid cancer to cerebellum with incidental medullary microcarcinoma

Paraneoplastic bullous pemphigoid – A sign of clear cell renal carcinoma

A 16-kb Antifuse One-Time-Programmable Memory in 5-nm High-K Metal-Gate FinFET CMOS Featuring Bootstrap High-Voltage Scheme, Read Endpoint Detection, and Pseudodifferential Sensing

Parathyroid Frozen Section Interpretation via Desktop Telepathology Systems: A Validation Study

Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events

A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab

Isolated cutaneous panniculitis in Sjögren’s disease exacerbated by COVID-19 illness

Mass Forming Basement Membrane Material Secondary to Adnexal Adenocarcinoma - a Case Report

Acute Truncal Lymphedema Secondary to Axillary Metastatic Melanoma Presenting Like Cellulitis

High concordance rate of HER2 status assessed via silver in situ hybridisation (SISH) between core biopsy and excision specimens: a 4 year retrospective review from a single institution

Cutaneous Nodules in the Genital Area in a Patient With Chronic Graft-vs-Host Disease

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies

PD‐1 inhibitor‐associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculation—Report of 4 cases

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature

Histologic Assessment of Lichenoid Dermatitis Observed in Patients With Advanced Malignancies on Antiprogramed Cell Death-1 (anti-PD-1) Therapy With or Without Ipilimumab

Dermoscopic image of radiotherapy associated benign lymphangiomatous papules

Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma

Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils

Panniculitis in patients treated with BRAF inhibitors: a case series

Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer

Extranodal NK/T cell lymphoma, nasal type presenting as widespread cutaneous rash

Duodenal plasma cells correspond to serum IgA in common variable immunodeficiency

Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma

Suchergebnisse filtern